ASSAY SYSTEM FOR GLP-2 RECEPTOR LIGANDS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150153329A1
SERIAL NO

14616295

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NPS PHARMACEUTICALS INC550 HILLS DRIVE THIRD FLOOR BEDMINSTER NJ 07921

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Demchyshyn, Lidia L Toronto, CA 6 6
Wang, Hong Hamilton, CA 1168 13527

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation